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ABSTRACT 
Incorporation of non-natural amino acids into proteins in vivo can provide 
biological materials with new chemical functions and improved physical properties. 
Examples include new posttranslational modification chemistry by introducing azide and 
ketone moieties into recombinant proteins, and novel strategies for engineering hyper-
stable proteins by incorporating fluorinated side chains. Implementing such methods 
requires manipulation of protein biosynthesis to specifically alter the genetic code.  The 
rules of the genetic code are established by theaminoacylation reaction, where the 
aminoacyl-tRNA synthetases (aaRS) catalyze the attachment of the amino acids to 
theircognate tRNAs.  Thus manipulation of cellular aminoacylation reactions could 
potentially expand the available set of amino acid building blocks for protein engineering 
and biomaterials engineering.   
 By simple depletion of the cellular pool of isoleucine and utilization of isoleucine 
auxotrophic hosts, we were able to force the endogenous isoleucyl-tRNA synthetase to 
join 5,5,5-trifluoroisoleucine (5TFI) to tRNAIle and assign it to isoleucine codons in vivo.  
Murine interleukin 2 containing 5TFI retains its biological activity.  We showed that 
engineering of bacterial expression hosts can allow a single RNA message to be read in 
different ways, depending on the relative rates of competing aminoacylation reactions.  
Specifically, we showed that the 2S,3R-form of 4,4,4-trifluorovaline can be assigned 
either to isoleucine or to valine codons, depending on whether the bacterial host 
overexpresses the isoleucyl- or the valyl-tRNA synthetase.   When anamino acid analog 
of interest is not recognizedby the corresponding wild-type aaRS, we can either identify 
the appropriate modification of the amino acid as a promising ligand or design new 
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synthetase activity.  We describe an attempt to develop a virtual ligand screening method 
to find non-natural amino acids that can serve as ligands for the phenylalanyl-tRNA 
synthetase and our computational results correlate well with experimental results in vitro 
and in vivo.  We also present a computational method for identifying the sites of 
mutations to relax the substrate specificity of the E. coli phenylalanyl-tRNA synthetase 
(ePheRS).  One designed variant of ePheRS allows the efficient in vivo incorporation of 
aryl ketone functionality into proteins in vivo.  Proteins outfitted with ketone 
functionality can be chemoselectively ligated with hydrazide reagents under mild 
conditions.  Three designed mutants of ePheRS were subjected to extensive examination, 
and a broad activation profile toward many non-natural aromatic amino acids was 
observed. E. coli host strains were established to over-express these mutant ePheRSs, 
enabling the re-assignment of the Phe codons to many non-natural amino acids.  By 
rational attenuation of the editing function of a leucyl-tRNA synthetase, oxonorvaline 
was incorporated into a recombinant protein in Escherichia coli. 
 The work described above addresses the multi-site incorporation of new amino 
acids into proteins in vivo, which can be utilized to engineer the overall properties of 
biomacromolecules such as protein stability.  The second component of this thesis 
focused on the site-specific incorporation of novel amino acids into proteins in vivo, 
which can be applied to problems that require local change of protein behavior.  We have 
refined a previously described system, where we introduce a mutant form of yeast PheRS 
co-transformed with a cognate suppressor tRNA, allowing incorporation of several 
aromatic amino acids into proteins in response to an amber codon.  The results firmly 
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demonstrate the general strategy of importing an exogenous synthetase/tRNA pair to 
achieve site-specific incorporation of non-natural amino acids into proteins in vivo.    
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